Ultragenyx Pharma (RARE) Prices 4.44M Share Common Offering at $90/Sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. ACN
3. IBM
4. MU
5. PRIM
6. DPZ
7. NAVN
8. NVDA
9. DFTX
10. META

Go back to Ultragenyx Pharma (RARE) Prices 4.44M Share Common Offering at $90/Sh

Ultragenyx Pharma (RARE) PT Raised to $116 at Cowen

October 28, 2020 6:59 AM EDT

Cowen analyst Yaron Werber raised the price target on Ultragenyx Pharma (NASDAQ: RARE) to $116.00 (from $90.00) while maintaining an Outperform rating.

The analyst commented, "RARE reported Q3:20 earnings with OpEx of $132M v our $128M estimates & steady growth in sales of Crysvita & Dojolvi.... More

Ultragenyx Pharma (RARE) PT Raised to $105 at Wedbush

October 28, 2020 6:28 AM EDT

Wedbush analyst Laura Chico raised the price target on Ultragenyx Pharma (NASDAQ: RARE) to $105.00 (from $97.00) while maintaining a Outperform rating.... More

Ultragenyx Pharma (RARE) PT Raised to $121 at Barclays

October 28, 2020 4:59 AM EDT

Barclays raised its price target on Ultragenyx Pharma (NASDAQ: RARE) to $121.00 (from $99.00) while maintaining a Overweight rating.... More

Ultragenyx Pharma (RARE) Tops Q3 EPS by 14c, Revenues Beat

October 27, 2020 4:45 PM EDT

Ultragenyx Pharma (NASDAQ: RARE) reported Q3 EPS of ($1.13), $0.14 better than the analyst estimate of ($1.27). Revenue for the quarter came in at $81.5 million versus the consensus estimate of $53.89 million.

Third quarter 2020 total revenue of $81.5 million and Crysvita revenue of $37.3 millionIncreased lower end of... More